Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study<sup>â</sup>.

Bandini, M; Gibb, E A; Gallina, A; Raggi, D; Marandino, L; Bianchi, M; Ross, J S; Colecchia, M; Gandaglia, G; Fossati, N; Pederzoli, F; Lucianò, R; Colombo, R; Salonia, A; Briganti, A; Montorsi, F; Necchi, A

Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study^â.

Bandini, M; Gibb, E A; Gallina, A; Raggi, D; Marandino, L; Bianchi, M; Ross, J S; Colecchia, M; Gandaglia, G; Fossati, N; Pederzoli, F; Lucianò, R; Colombo, R; Salonia, A; Briganti, A; Montorsi, F; Necchi, A.

Afiliación

Bandini M; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Gibb EA; Decipher Biosciences Inc., Vancouver, Canada.
Gallina A; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Marandino L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Bianchi M; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Ross JS; Foundation Medicine Inc., Cambridge, United States; Upstate Medical University, Syracuse, United States.
Colecchia M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gandaglia G; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Fossati N; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Pederzoli F; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Lucianò R; Department of Pathology, IRCCS Ospedale San Raffaele, Milan, Italy.
Colombo R; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Salonia A; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Briganti A; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Montorsi F; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it.

Ann Oncol ; 31(12): 1755-1763, 2020 12.

Article en En | MEDLINE | ID: mdl-32979511

Asunto(s)

Cistectomía; Neoplasias de la Vejiga Urinaria; Anticuerpos Monoclonales Humanizados; Quimioterapia Adyuvante; Supervivencia sin Enfermedad; Humanos; Terapia Neoadyuvante; Recurrencia Local de Neoplasia/tratamiento farmacológico; Estudios Retrospectivos; Resultado del Tratamiento; Neoplasias de la Vejiga Urinaria/tratamiento farmacológico; Neoplasias de la Vejiga Urinaria/cirugía

Palabras clave

event-free survival; muscle-invasive bladder cancer; pathological response; pembrolizumab; radical cystectomy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistectomía Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google